Abstract
The evaluation of copy number variants (CNVs), loss of heterozygosity (LOH), and sequence variants provides valuable clinical information for the diagnosis and prognosis of both hematologic malignancies and solid tumors. In our laboratories, genomic profiling is typically performed using chromosomal microarray analysis (CMA), Sanger sequencing and next generation sequencing (NGS) assays. The data are analyzed individually with different software tools and then combined in an integrated report.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
